https://www.selleckchem.com/pr....oducts/Monensin-sodi
outcomes. MDR-TB treatment success in Sierra Leone approached WHO targets and the short regimen was associated with higher success. The social and health factors associated with adverse outcomes in this study suggest a role for integrated tuberculosis, HIV, and non-communicable disease services alongside nutritional and socioeconomic support for people with MDR-TB and emphasise the urgent need to scale up coverage of all-oral aminoglycoside-sparing regimens. Wellcome Trust, Joint Global Health Trials. Wellcome Trust,
Like
Comment
Share
